✦ LIBER ✦

Augmented high dose cyclophosphamide, etoposide, and carmustine followed by transplantation with peripheral blood stem cells (PBSC) in the treatment of relapsed or refractory Hodgkin’s disease

✍ Scribed by J.E. Schwartz; M.J. Robertson; K.G. Cornetta; L.D. Cripe; R.P. Nelson; C.T. Yiannoutsos; J.A. Baute; L.L. Wood; R. Abonour

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, etoposide, cytarabine, and d

✍ P. Schütt; J. Passon; P. Ebeling; A. Welt; S. Müller; K. Metz; T. Moritz; S. See 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Treatment of relapsed or refractory Hodg

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

High-dose therapy with peripheral blood

✍ K. Neben; S. Hohaus; H. Goldschmidt; G. Egerer; M. T. Voso; A. D. Ho; R. Haas 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 118 KB

A Phase I Trial of High-Dose Clofarabine

✍ Shivani Srivastava; David Jones; Lisa L. Wood; Jennifer E. Schwartz; Robert P. N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Feasibility and Efficacy of High-Dose Me

✍ Li-na Han; Jin Zhou; Takayuki Hirose; Yosuke Imai; Takuro Ishiguro; Takaaki Chou 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 137 KB

Early and Late Complications Associated

✍ N. Vidula; B. Jovanovic; J. Winter; J. Mehta; S. Singhal; S. Williams; O. Frankf 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB